Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Nuocheng Pharmaceutical is a Chinese biopharmaceutical company specializing in the development and manufacture of human vaccines. As a subsidiary of Liaoning Cheng Da Biotechnology (Chengda Bio), the company is a key producer of the freeze-dried human rabies vaccine (Vero cell) in China. Based in Huzhou, Zhejiang, it operates large-scale GMP-certified manufacturing facilities dedicated to high-quality biological production. The company focuses on the prevention of infectious diseases and contributes significantly to the domestic supply of essential vaccines. Its operations are integrated into the broader vaccine portfolio of its parent company, leveraging advanced Vero cell culture technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Nuocheng Pharmaceutical.